EUVIMEDEUVIMED entdecken
Crossref

Rapid increase of C/EBPα p42 induces growth arrest of acute myeloid leukemia (AML) cells by Cop1 deletion in Trib1-expressing AML

Yoshitaka Sunami, Seiko Yoshino iD, Yukari Yamazaki, Takashi Iwamoto, Takuro Nakamura iD

Leukemia · 2024

DOI: 10.1038/s41375-024-02430-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Leukemia, 2024. Verfasst von Yoshitaka Sunami und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Pathology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Protein Serine-Threonine Kinases, Intracellular Signaling Peptides and Proteins, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cop1 encodes a ubiquitin E3 ligase that has been well preserved during evolution in both plants and metazoans. In metazoans, the C/EBP family transcription factors are targets for degradation by Cop1, and this process is regulated by the Tribbles pseudokinase family. Over-expression of Tribbles homolog 1 (Trib1) induces acute myeloid leukemia (AML) via Cop1-dependent degradation of the C/EBPα p42 isoform. Here, we induced rapid growth arrest and granulocytic differentiation of Trib1-expressing AML cells using a Cop1 conditional knockout (KO), which is associated with a transient increase in the C/EBPα p42 isoform. The growth-suppressive effect of Cop1 KO was canceled by silencing of Cebpa and reinforced by exogenous expression of the p42 isoform. Moreover, Cop1 KO improved the survival of recipients transplanted with Trib1-expressing AML cells. We further identified a marked increase in Trib1 protein expression in Cop1 KO, indicating that Trib1 is self-degraded by the Cop1 degradosome. COP1 downregulation also inhibits the proliferation of human AML cells in a TRIB1-dependent manner. Taken together, our results provide new insights into the role of Trib1/Cop1 machinery in the C/EBPα p42-dependent leukemogenic activity, and a novel idea to develop new therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteProtein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsUbiquitin-Protein LigasesAnimalsMiceHumansCell ProliferationCCAAT-Enhancer-Binding ProteinsMice, KnockoutCell DifferentiationProtein IsoformsCCAAT-Enhancer-Binding Protein-alphaNuclear Proteins

Substanzen

Protein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsUbiquitin-Protein LigasesCCAAT-Enhancer-Binding ProteinsCOP1 protein, mouseTrib1 protein, mouseCOP1 protein, humanTRIB1 protein, humanProtein IsoformsCCAAT-Enhancer-Binding Protein-alpha

Autor:innen und Institutionen

  • Department of Experimental Pathology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.
  • Department of Molecular Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Experimental Pathology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan. takuron@tokyo-med.ac.jp.

ORCID-Profile: Seiko Yoshino, Takuro Nakamura

Förderung

  • MEXT | Japan Society for the Promotion of Science (JSPS)

Zitieren

APA

Sunami, Y., Yoshino, S., Yamazaki, Y., Iwamoto, T., & Nakamura, T. (2024). Rapid increase of C/EBPα p42 induces growth arrest of acute myeloid leukemia (AML) cells by Cop1 deletion in Trib1-expressing AML. Leukemia. https://doi.org/10.1038/s41375-024-02430-4

Vancouver

Sunami Y, Yoshino S, Yamazaki Y, Iwamoto T, Nakamura T. Rapid increase of C/EBPα p42 induces growth arrest of acute myeloid leukemia (AML) cells by Cop1 deletion in Trib1-expressing AML. Leukemia. 2024. doi:10.1038/s41375-024-02430-4

BibTeX
@article{Sunami2024,
  author = {Sunami, Yoshitaka and Yoshino, Seiko and Yamazaki, Yukari and Iwamoto, Takashi and Nakamura, Takuro},
  title = {Rapid increase of C/EBPα p42 induces growth arrest of acute myeloid leukemia (AML) cells by Cop1 deletion in Trib1-expressing AML},
  journal = {Leukemia},
  year = {2024},
  doi = {10.1038/s41375-024-02430-4}
}
Kostenlos starten →